Literature DB >> 30366587

Effects of long-term respiratory muscle endurance training on respiratory and functional outcomes in patients with Myasthenia gravis.

Sophie Freitag1, Stephanie Hallebach1, Irene Baumann2, Petra Kalischewski3, Beate Rassler4.   

Abstract

BACKGROUND: Myasthenia gravis (MG) is characterized by reduced muscle endurance and often leads to respiratory complications.
OBJECTIVE: A long-term respiratory muscle endurance training (RMET) based on normocapnic hyperpnea was introduced for the first time in MG patients. We investigated RMET effects on respiratory endurance (RE), MG symptoms, lung function and physical fitness and compared the results with a control group (CG).
METHODS: The training period consisted of four weeks intensive training (IT; five 30-min training sessions per week) followed by twelve months maintenance training (MT; five 30-min training sessions over two weeks). Eighteen patients with mild to moderate MG participated as the training group (TG), six patients served as CG. RE, lung function, MG score and physical fitness were tested before and after IT and after three to twelve months of MT.
RESULTS: Only 12 TG patients completed the entire training period. Thirteen months of training significantly increased RE measured as time until exhaustion (Tlim) to 412% of baseline (P < 0.001). The MG score improved from 0.67±0.09 to 0.41 ± 0.1 (p = 0.004), and the number of squats per minute as a measure of physical fitness increased in the TG to 160% of baseline (p = 0.015). While lung function did not change during the training period, we observed a modulation in the breathing pattern at rest with prolonged expiration (122% of baseline, p = 0.028). In addition, TG reported subjective improvements in MG symptoms, respiratory symptoms and physical fitness by 49%, 58% and 64%, respectively (P < 0.001). No significant changes were observed in the CG. CONCLUSION AND SIGNIFICANCE: This is the first controlled long-term RMET study in MG patients. The results demonstrated that this normocapnic hyperpnea training is feasible and beneficial for patients with mild to moderate MG and is a valuable supplement to conventional drug treatment.
Copyright © 2018. Published by Elsevier Ltd.

Entities:  

Keywords:  Besinger score; Lung function; Myasthenia gravis; Respiratory endurance; Respiratory muscle endurance training; Respiratory muscle strength

Mesh:

Year:  2018        PMID: 30366587     DOI: 10.1016/j.rmed.2018.09.001

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  5 in total

Review 1.  A Practical Approach to Managing Patients With Myasthenia Gravis-Opinions and a Review of the Literature.

Authors:  Maria Elena Farrugia; John A Goodfellow
Journal:  Front Neurol       Date:  2020-07-07       Impact factor: 4.003

2.  Effect of Respiration Training-Assisted Western Medicine Therapy on Activity Tolerance, Pulmonary Function, and Quality of Life of Chronic Obstructive Pulmonary Disease Patients in the Stable Phase.

Authors:  Yaqi Tong; Jia Cui; Di Chai
Journal:  J Healthc Eng       Date:  2022-03-30       Impact factor: 2.682

Review 3.  Inspiratory Muscle Rehabilitation Training in Pediatrics: What Is the Evidence?

Authors:  Dharini M Bhammar; Harrison N Jones; Jason E Lang
Journal:  Can Respir J       Date:  2022-08-18       Impact factor: 2.130

4.  Respiratory Muscle Training Improves Functional Outcomes and Reduces Fatigue in Patients with Myasthenia Gravis: A Single-Center Hospital-Based Prospective Study.

Authors:  Che-Wei Hsu; Hui-Chen Lin; Wan-Chen Tsai; Yun-Ru Lai; Chih-Cheng Huang; Yu-Jih Su; Ben-Chung Cheng; Mao-Chang Su; Wei-Che Lin; Chia-Ling Chang; Wen-Neng Chang; Meng-Chih Lin; Cheng-Hsien Lu; Nai-Wen Tsai
Journal:  Biomed Res Int       Date:  2020-03-19       Impact factor: 3.411

5.  Effect of Two Different Rehabilitation Approaches on Pulmonary Functional Tests, Neuromuscular Functions and Quality of Life in Juvenile Myasthenia Gravis: A Randomized Controlled Trial Study.

Authors:  Rasha A Mohamed; El Sayed H Mohamed; Mohamed A Basiouny; Ibrahim M Hamoda; El Sayed M Hanoura; Elbadawy I Elhenedi; Abd El Aziz A Sherief
Journal:  Medicina (Kaunas)       Date:  2022-03-02       Impact factor: 2.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.